These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 186350)

  • 21. Characterization of novel splice variants of the PAC1 receptor in human neuroblastoma cells: consequences for signaling by VIP and PACAP.
    Lutz EM; Ronaldson E; Shaw P; Johnson MS; Holland PJ; Mitchell R
    Mol Cell Neurosci; 2006 Feb; 31(2):193-209. PubMed ID: 16226889
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cyclic AMP and bicarbonate responses of the dog pancreas to vasoactive intestinal peptide (VIP) and secretion.
    Konturek SJ; Domschke S; Domschke W; Dembiński A; Król R; Demling L
    J Lab Clin Med; 1976 Oct; 88(4):608-13. PubMed ID: 184219
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Binding of vasoactive intestinal peptide and its stimulation of adenylate cyclase through two classes of receptors in rat liver membranes. Effects of 12 secretin analogues and 2 secretin fragments.
    Waelbroeck M; Robberecht P; De Neef P; Chatelain P; Christophe J
    Biochim Biophys Acta; 1981 Nov; 678(1):83-90. PubMed ID: 6272875
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pancreatic secretagogues regulate somatostatin binding to acinar cell membranes via two-functionally distinct pathways.
    Matozaki T; Sakamoto C; Nagao M; Baba S
    Horm Metab Res; 1988 Mar; 20(3):141-4. PubMed ID: 2898426
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis and some pharmacological properties of the 23-peptide 15-lysine-secretin-(5--27). Special role of the residue in position 15 in biological activity of the vasoactive intestinal polypeptide.
    Bodansky M; Natarajan S; Gardner JD; Makhlouf GM; Said SI
    J Med Chem; 1978 Nov; 21(11):1171-3. PubMed ID: 214557
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Receptors for vasoactive intestinal peptide and secretin on rat pancreatic acini.
    Bissonnette BM; Collen MJ; Adachi H; Jensen RT; Gardner JD
    Am J Physiol; 1984 Jun; 246(6 Pt 1):G710-7. PubMed ID: 6204536
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Receptors for vasoactive intestinal peptide and secretin on small intestinal epithelial cells.
    Binder HJ; Lemp GF; Gardner JD
    Am J Physiol; 1980 Mar; 238(3):G190-6. PubMed ID: 6245588
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization of secretin and vasoactive intestinal peptide receptors in rat pancreatic plasma membranes using the native peptides, secretin-(7-27) and five secretin analogues.
    Robberecht P; Waelbroeck M; Noyer M; Chatelain P; De Neef P; König W; Christophe J
    Digestion; 1982; 23(3):201-10. PubMed ID: 6286393
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Actions of vasoactive intestinal peptide and secretin on chief cells prepared from guinea pig stomach.
    Sutliff VE; Raufman JP; Jensen RT; Gardner JD
    Am J Physiol; 1986 Jul; 251(1 Pt 1):G96-102. PubMed ID: 3014896
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Control of cyclic AMP accumulation in dog acini: its relation to amylase release.
    Laval J; Bommelaer G; Senarens C; Vaysse N; Ribet A
    Digestion; 1983; 28(2):82-9. PubMed ID: 6197335
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Use of 125I-secretin to identify and characterize high-affinity secretin receptors on pancreatic acini.
    Jensen RT; Charlton CG; Adachi H; Jones SW; O'Donohue TL; Gardner JD
    Am J Physiol; 1983 Aug; 245(2):G186-95. PubMed ID: 6309017
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vasoactive intestinal peptide receptor antagonist [4Cl-D-Phe6, Leu17] VIP.
    Pandol SJ; Dharmsathaphorn K; Schoeffield MS; Vale W; Rivier J
    Am J Physiol; 1986 Apr; 250(4 Pt 1):G553-7. PubMed ID: 2421587
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reduced peptide bond pseudopeptide analogues of secretin. A new class of secretin receptor antagonists.
    Haffar BM; Hocart SJ; Coy DH; Mantey S; Chiang HC; Jensen RT
    J Biol Chem; 1991 Jan; 266(1):316-22. PubMed ID: 1702423
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The C-terminal part of VIP is important for receptor binding and activation, as evidenced by chimeric constructs of VIP/secretin.
    Wulff B; Møller Knudsen S; Adelhorst K; Fahrenkrug J
    FEBS Lett; 1997 Aug; 413(3):405-8. PubMed ID: 9303545
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Actions of Gila monster venom on dispersed acini from guinea pig pancreas.
    Raufman JP; Jensen RT; Sutliff VE; Pisano JJ; Gardner JD
    Am J Physiol; 1982 May; 242(5):G470-4. PubMed ID: 6177252
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Secretin stimulates cyclic AMP formation in the rat brain.
    Fremeau RT; Korman LY; Moody TW
    J Neurochem; 1986 Jun; 46(6):1947-55. PubMed ID: 3009718
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Actions of VIP, hGRF, PHI and secretin: comparative studies in cerebral cortex and adenohypophysis.
    Magistretti PJ; Schönenberg P; Kehrer P; Martin JL; Gaillard RC
    Peptides; 1986; 7 Suppl 1():175-80. PubMed ID: 3018695
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of secretin and VIP on isolated pancreatic duct fragments in vitro.
    Creutzfeldt W; Foelsch UR
    Endocrinol Jpn; 1980 Dec; 27 Suppl 1():59-63. PubMed ID: 6262064
    [TBL] [Abstract][Full Text] [Related]  

  • 39. VIP regulation of a human pancreatic cancer cell line: Capan-1.
    Ruellan C; Scemama JL; Clerc P; Fagot-Revurat P; Clemente F; Ribet A
    Peptides; 1986; 7 Suppl 1():267-71. PubMed ID: 3018700
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Presence of VIP receptors in a human pancreatic adenocarcinoma cell line. Modulation of the cAMP response during cell proliferation.
    Estival A; Mouniélou P; Trocheris V; Scemama JL; Clemente F; Hollande E; Ribet A
    Biochem Biophys Res Commun; 1983 Mar; 111(3):958-63. PubMed ID: 6301493
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.